Noninvasive biomarkers in the diagnosis of prostate cancer

Prostate cancer is responsible for 3% of all deaths in the Western world in men over 55 years old. Molecular biomarkers represent an important diagnostic tool in prostate cancer, because at a specific stage, they reflect the physiologic state of a cell and might be vital for the identification of ea...

Full description

Bibliographic Details
Main Authors: Raluca Dumache, Maria Puiu, Adriana Kaycsa, Dana David, Marinela Popovici, Daniela Ionescu, Florin Miclea
Format: Article
Language:English
Published: "Alexandru Ioan Cuza" University of Iași 2010-06-01
Series:Analele Ştiinţifice Ale Universităţii Alexandru Ioan Cuza din Iași,Sectiunea II A : Genetica si Biologie Moleculara
Online Access:http://www.gbm.bio.uaic.ro/index.php/gbm/article/view/774
Description
Summary:Prostate cancer is responsible for 3% of all deaths in the Western world in men over 55 years old. Molecular biomarkers represent an important diagnostic tool in prostate cancer, because at a specific stage, they reflect the physiologic state of a cell and might be vital for the identification of early prostate cancer and subjects at risk of developing this disease. Many biomarkers have been described in human serum, urine, seminal fluid and histological specimens that exhibit varying capacities to detect prostate cancer, to monitor the disease progression, help in predicting the disease recurrence and therapeutic treatment efficacy
ISSN:1582-3571
2248-3276